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Abstract: Autophagy is an evolutionarily conserved catabolic process which allows lysosomal
degradation of complex cytoplasmic components into basic biomolecules that are recycled for further
cellular use. Autophagy is critical for cellular homeostasis and for degradation of misfolded proteins
and damaged organelles as well as intracellular pathogens. The role of autophagy in protection
against age-related diseases and a plethora of other diseases is now coming to light; assisted by
several divergent eukaryotic model systems ranging from yeast to mice. We here give an overview
of different methods used to analyse autophagy in zebrafish—a relatively new model for studying
autophagy—and briefly discuss what has been done so far and possible future directions.
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1. Introduction
Over the past few decades we have seen a dramatic surge in research on a basic and fundamental
cellular process called autophagy. Autophagy is defined as the lysosomal degradation of cytoplasmic
materials (proteins, lipids, organelles, etc.), and three major types of autophagy have been described:
macroautophagy, microautophagy and chaperone-mediated autophagy [1]. This review will focus on
macroautophagy (hereafter referred to as autophagy), which involves the sequestration of cytoplasmic
components in a double membranous structure, the autophagosome, followed by its fusion to the
acidic lysosome, resulting in cargo degradation and release of simple biomolecules that can be
reused for varied cellular purposes (Figure 1A). Thus, autophagy is an adaptive catabolic process
leading to substrate formation for further anabolic energy-generating processes, to ultimately maintain
homeostasis at the cell, tissue and organism levels.
The molecular era of autophagy started with a series of genetic screens performed on unicellular
yeast in the 1990s [2–5], which were followed by the identification of respective homologs in higher
eukaryotes and resulted in the characterization of more than 30 AuTophaGy-related (ATG) genes [6].
The ATG proteins essential for autophagosome formation are referred to as the ‘core’ autophagy
machinery (Figure 1B) [7] and include: (1) the UNC-51-like kinase (ULK) complex composed of ULK1
or ULK2, ATG13, ATG101 and FIP200; (2) the class III phosphatidylinositol 3-kinase (PI3K) complex
(PIK3C3), consisting of the catalytic subunit VPS34, as well as BECLIN1, p150 and ATG14L; (3) the
two ubiquitin-like conjugation systems that lead to the conjugation of ATG12 to ATG5 and ATG8
to phosphatidylethanolamine (PE) in the phagophore membrane and finally (4) the transmembrane
protein ATG9 [8,9]. Human ATG protein names are used here, see Table 1 for the respective zebrafish
ATG orthologue names.
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Table 1. Zebrafish (Danio rerio) orthologues of human autophagy genes, with amino acid percentage identity and allele availability at the Sanger ZMP. ULK:
UNC-51-like kinase; ZMP: Zebrafish Mutation Project; PE: phosphatidylethanolamine, mTORC1: Mammalian Target of Rapamycin Complex 1, AMPK: Adenosine
Mono-Phosphate Kinase; ER: Endoplasmic Reticulum; PtdIns3K: Phosphatidylinositol 3-Kinase; VPS34: Vacuolar Protein Sorting 34.
Core Autophagic Process MammalianProtein
Zebrafish
Orthologue













ulk1a NM_001130631,NP_001124103.1 ENSDART00000090534.4 50%
Phosphorylated by mTORC1




ulk1b XM_005161121.3,XP_005161178.1 ENSDART00000112407.3 No
ULK2 ulk2 XM_002664615.4,XP_002664661.3 ENSDART00000153726 74% No
ATG13/
KIAA0652 atg13 NM_200433, NP_956727 ENSDART00000052324.5 71%
Member of the ULK1 complex,






XP_009300473.1 ENSDART00000113014.3 59% Scaffold for ULK1/2 and ATG13 Yes





ATG14L atg14L/kiaa0831 NM_001024812,NP_001019983 ENSDART00000018683.10 67%
Autophagy-specific subunit of PIK3C3









Beclin1 beclin1 NM_200872, NP_957166 ENSDART00000115237.3 79% Subunit of PIK3C3. Regulatoryfunction through binding to Bcl-2 Yes
p150 pik3r4 XM_005158299.3,XP_001922676.1 ENSDART00000085228.5 82% Adaptor protein for VPS34 No
Atg12 conjugation system
ATG12 atg12 NM_001246200,NP_001233129 ENSDART00000101304.4 71% Ubiquitin like, conjugates to ATG5 Yes
ATG7 atg7 XM_017358254.1,XP_017213743.1 ENSDART00000162152 77% E1-like enzyme Yes
ATG10 atg10 NM_001037124,NP_001032201.1 ENSDART00000160159.1 50% E2-like enzyme No
ATG5 atg5/apg5L NM_205618, NP_991181 ENSDART00000029727.6 81% Conjugated by ATG12 Yes
ATG16L1 atg16L1 NM_001017854,NP_001017854 ENSDART00000161937.1 69%
Interacts with ATG5 to form the
ATG12-5-16L1 complex, an E3 like
ligase for Atg8 conjugation
No
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MAP1-Lc3A map1-lc3a NM_214739, NP_999904 ENSDART00000042322.3 96%
Ubiquitin like, conjugates to PE NoMAP1-Lc3B map1-lc3b NM_199604, NP_955898 ENSDART00000163508.1 93%
MAP1-Lc3C map1-lc3c NM_200298, NP_956592 ENSDART00000161846.2 72%
GABARAP gabarapa NM_001013260,NP_001013278 ENSDART00000051547.3 98% Ubiquitin like, conjugates to PE No
GABARAPL1 gabarapl1 NM_001002707,NP_001002707 ENSDART00000060037.3 59%
GABARAPL2 gabarapl2 NM_205723, NP_991286 ENSDART00000039485.6 97%




ATG4B atg4b NM_001089352,NP_001082821 ENSDART00000121558.3 73% No
ATG4C atg4c NM_001002103,NP_001002103 ENSDART00000051779.3 59% Yes
ATG4D atg4da XM_009294436.2,XP_009292711.1 ENSDART00000152289.2 50% No
atg4db ENSDART00000172196 50% No
ATG3 atg3 NM_200022, NP_956316 ENSDART00000041304.7 82% E2-like enzyme No
Other core Atg proteins during
autophagosome formation
ATG2A atg2a XM_009307758.2,XP_009306033.1 ENSDART00000172444.1 55% Proper closure of autophagosome No
ATG2B atg2b XP_001340508.3 ENSDART00000155615 42% No
ATG9A atg9a NM_001083031,NP_001076500 ENSDART00000065411.6 71%
Transmembrane protein on the
autophagsome
No
ATG9B atg9b NM_001320078,NP_001307007 ENSDART00000147499.3 49% No




WIPI2 wipi2 NM_001327789,NP_001314718 ENSDART00000134026.2 82% Yes
WIPI3/
WDR45B wipi3/wdr45b NM_200240, NP_956534 ENSDART00000152327.2 96% No
WDR45 wipi4 NM_200231, NP_956525 ENSDART00000130229.2 90% No
Autophagy receptor proteins




NP_001299842 ENSDART00000140061.2 44% Autophagy cargo receptor No





Autophagy cargo receptor during
xenophagy and mitophagy No
NBR1 nbr1 NM_001305595,NP_001292524 ENSDART00000133048.2 38% Autophagy cargo receptor Yes
TAX1BP1 tax1bp1a NM_001346178,NP_001333107 ENSDART00000171664.1 44%
Autophagy cargo receptor during
mitophagy Yes
tax1bp1b NM_212664, NP_997829 ENSDART00000040727.7 52% Autophagy cargo receptor Yes
Cells 2017, 6, 21 4 of 26




Figure 1. (A) Schematic overview of the process of macroautophagy; (B) Schematic overview of 
the core autophagic proteins involved in autophagosome biogenesis. 
In addition to these core autophagy proteins, the regulation and execution of the pathway is 
tightly controlled by a large number of proteins and lipids and we are only beginning to understand 
how their interconnections are regulated in time and space under various metabolic conditions and 
in different tissues. Dysfunctional autophagy is closely associated with tumorigenesis [10,11], 
immune disorders [12], neurodegeneration and aging [13], infectious diseases [14] and diabetes [15]. 
Thus, a detailed understanding of the molecular mechanisms involved in autophagy may open doors 
to various therapeutic approaches against diseases where autophagy plays an indispensable role.  
Our understanding of how autophagy is regulated under different physiological and 
pathological conditions is largely based on research performed in different tractable animal model 
systems such as the fruit fly Drosophila melanogaster [16,17], nematode Caenorhabditis elegans [18], the 
mouse Mus musculus [19,20], oysters [21] and Dictyostelium discoideum [22]. Recently, there has been 
an exponential interest in using zebrafish (Danio rerio) for varied research owing to the immense 
advantages that it offers. The small size, high fecundity, external fertilization, transparent embryos, 
rapid development, and genetic tractability of zebrafish make it highly desirable for basic science and 
translational high throughput research [23].  
We here review the current literature and the methods used to study autophagy in zebrafish, 
including DNA, RNA and protein-based methods. We also discuss different types of selective 
autophagy, with emphasis on mitophagy, xenophagy and aggrephagy and how these can be studied 
in zebrafish. Finally, we provide detailed information about different antibodies, chemical reagents 
Figure 1. (A) Schematic overview of the process of macroautophagy; (B) Schematic overview of the
core autophagic proteins involved in autophagosome biogenesis.
In addition to thes core autophagy protein , the regulation and ex cution of the pathway is
tightly controlled by a large number of proteins and lipids and we are only beginning to understand
how their interconnections are regulated in time and space under various metabolic conditions and in
different tissues. Dysfuncti nal autophagy is closely associated with tumorigenesis [10,11], immune
disorders [12], neurodegeneration and aging [13], infectious diseases [14] and diabetes [15]. Thus,
a detailed understandi g of th molecular mechanisms involved in autophagy may open doors to
various therapeutic approaches against diseases where autophagy plays an indispensable role.
Our understanding of how autophagy is regulated under different physiological and pathological
conditions is largely based on research perfor ed in different tractable animal model systems such
as the fruit fly Drosophila melanogaster [16,17], nematode Caenorhabditis elegans [18], the mouse Mus
musculus [19,20], oysters [21] and Dictyostelium discoideum [22]. Recently, there has been an exponential
interest in using zebrafish (Danio rerio) for varied research owing to the immense advantages that it
offers. The small size, high fecundity, external fertilization, transparent embryos, rapid development,
and genetic tractability of zebrafish make it highly desirable for basic science and translational high
throughput research [23].
We here review the current literature and the methods used to study autophagy in zebrafish,
including DNA, RNA and protein-based methods. We also discuss different types of selective
autophagy, with emphasis on mitophagy, xenophagy and aggrephagy and how these can be studied
in zebrafish. Finally, we provide detailed information about different antibodies, chemical reagents
and reporter lines that have been used to analyze autophagy in zebrafish and discuss how current
methods could be improved to better understand autophagy in zebrafish.
2. Zebrafish Autophagy Genes
The identification of the zebrafish as a genetically tractable organism in the 1980s led to its
immense usage in the 1990s, whereby a large number of mutations giving rise to specific phenotypes
were discovered through large-scale mutagenesis screens [24]. However, this alone was insufficient
to throw light on various rare and common human disorders as a high-quality zebrafish genome
Cells 2017, 6, 21 5 of 26
sequence and complete annotation of zebrafish protein-coding genes with identification of their human
orthologues was limited. The genome of the zebrafish has now been published as a well-annotated
reference genome, providing key insights into the use of this vertebrate as a desirable model to mimic
human disease states. In total, 84% of human disease-associated genes have at least one obvious
zebrafish orthologue [25–27].
To be able to alter or modulate autophagy genetically in zebrafish, it is critical to delineate the
representative ATG zebrafish orthologues from its yeast or mammalian counterparts. We searched for
human ATG proteins from National Centre for Biotechnology Information (NCBI) and blasted their
respective amino acid sequences against Danio rerio’s (taxid: 7955) reference proteins as a search set.
The hit with highest query coverage and smallest E-value was selected to be an orthologue. We also
compared the sequence with that annotated in the Ensemble genome browser. A detailed account of
the core ATG proteins (mammalian) and their respective zebrafish orthologue with Refseq IDs and
Ensemble IDs have been tabulated (Table 1). The overall amino acid identity between human and
zebrafish core autophagy proteins range between 40 and 96% (Table 1).
3. Genome Editing Techniques
Genome editing, or the idea of introducing a desired change to the genomic DNA sequence,
is currently driving a revolution in the medical field with the introduction of the Clustered
Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR Associated Protein 9 (Cas9)
technology [28–30]. An ideally desirable genome editing tool would edit any genomic locus with high
efficiency, specificity and with little or no off-target effects. The basic process of nuclease-based genome
editing is to create a specific double-strand break (DSB) in the genome and then allow the cell’s own
endogenous repair machinery to repair the break, by either non-homologous end-joining (NHEJ) or
by homology-directed repair (HDR). The different techniques of genome editing used in zebrafish
(CRISPR/Cas9, transcription activator-like effector nucleases (TALENs) and zinc finger nucleases)
have been extensively reviewed elsewhere [31–37]. We will here discuss how genome editing could
help drive the field of zebrafish autophagy.
3.1. CRISPR/Cas9 Mutagenesis
The CRISPR/Cas9 technology has been widely adopted in the zebrafish community and has
already come a long way from the first knock-out [38], to high-throughput mutagenesis screens [33],
conditional knockout [39], multiplex knockout [40,41] and to targeted insertion of DNA elements [42].
It would be highly desirable to apply systematically all of these techniques into understanding the
precise role of autophagy proteins in zebrafish development, physiology and pathology.
Briefly, CRISPR/Cas9-mediated genome editing in zebrafish is facilitated by the microinjection of
a “short guide-RNA” (sgRNA) and Cas9 endonuclease protein into zebrafish embryo (at 1 cell stage),
wherein the Cas endonuclease protein, forms a complex with the sgRNA molecule (now called the Cas9
holoendonuclease). Cas9 holoendonuclease or the corresponding RNAs (sgRNA + Cas9 messenger
RNA (mRNA)) can be injected. The target DNA sequence, in addition to being complementary to
the gRNA molecule, should also have a “protospacer-adjacent motif” (PAM), that is required for
compatibility with the particular Cas protein being used. Once mobilized to the target DNA site,
the Cas9 holoendonuclease generates a double-strand break (DSB), which can be used to create a
knock-out or add a specific function to a gene (targeted knock-in). Autophagy can be manipulated
by injecting sgRNA against the core autophagy genes (Table 1) together with either Cas9 mRNA
or protein. It is very important to minimize or best, to negate, mutagenesis of an incorrect gene
(off-target effect). Step-by-step protocols describing how to design an efficient sgRNA and the heuristic
rules surrounding it, purifying Cas9 mRNA or using commercial Cas9 protein along with sgRNA
have been reviewed previously [43,44]. The transparency of zebrafish larvae makes zebrafish highly
desirable to use for generation of reporter lines. CRISPR/Cas9 can be used to tag core autophagy genes
endogenously by “knocking-in” a reporter DNA element upstream/downstream of the autophagy
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gene of interest, e.g., to generate a fusion protein at an endogenous locus. This is highly desirable
in the study of autophagy, opening up the prospect of “double-tagging” an autophagy protein or a
cargo of interest and following their degradation kinetics. “Double-tagging” is based on the principle
of using tandem fluorescent tags, where one will be quenched (e.g., green fluorescent protein (GFP))
upon delivery to the acidic lysosome. CRISPR/Cas9-mediated genome editing can also used to ablate
a particular gene in a specific tissue or at a particular developmental time-point. As an example, LoxP
sites can be “knocked-in” to flank an autophagy gene of interest and later by using the cre recombinase,
the gene can be inverted or excised, thereby creating a complete knock-out. This is suitable for genes
whose knockout can be embryonically lethal.
The use of CRISPR/Cas9-based targeted mutagenesis for deriving stable transgenic zebrafish
or zebrafish knockout autophagy lines is in its initial phase. So far only one study has used this
system to create mutant lines. CRISPR/Cas9-based mutagenesis in spns1 and atp6v0ca genes induced
premature autophagosome-lysosome fusion marked by insufficient acidity leading to developmental
senescence and death [45]. spns1 is thought to function as a lysosomal H+-carbohydrate symporter,
which functions at a late and terminal stage of autophagy [46,47]. atp6v0ca encodes a sub-unit of
the vacuolar-type H+-ATPase (v-ATPase) that counteracts spns1 ablation effects in zebrafish. It is
highly likely that we will soon see increasing use of CRISPR/Cas9 technology to modulate autophagy
in zebrafish.
3.2. TALENS and ZFNs
Since the introduction of CRISPR/Cas9 for genome editing in zebrafish, the use of TALENs and
ZFNs, which were used before for genome editing [36,37] have taken a back seat (for a review of these
methods see references). The use of TALENs and ZFNs to study autophagy in zebrafish is limited.
TALEN-mediated mutation of the nuclear hormone receptor nr1d1 was shown to have a positive effect
on autophagosome-autolysosome number and lead to upregulation of ATG genes. nr1d1 mutants were
also shown to affect the circadian clock by significantly upregulating the circadian clock genes, leading
to the conclusion that the circadian clock regulates autophagy rhythms in zebrafish larvae [48].
3.3. Transient Gene Knockdown by Morpholino Oligonucleotides
Morpholino oligonucleotides or morpholinos, first developed by Dr. James Summerton, are
oligomers of 25 morpholine bases that are targeted via complementary base pairing to the mRNA
of interest. They silence the gene by either blocking the translational start site from the ribosomal
machinery or by blocking the splice sites (donor/acceptor), thereby interfering with the binding of
spliceosome components [49,50]. Morpholinos can be used to interrogate pathways and associate genes
with a phenotype and this can be done easily by just injecting an optimal volume of the morpholino
solution into the yolk sac of a zebrafish embryo at the 1–4 cell stage. Morpholinos provide precise
spatial targeting of multiple gene products [51] and are extremely useful for silencing and analyzing
maternal gene expression [52]. However, a drawback of morpholinos is the relatively frequent off-target
effects. Off-target effects are often caused by the induction of p53 that leads to apoptosis, but can also
be p53-independent [53,54]. Inconsistencies between morphant and CRISPR mutant phenotypes have
been seen in some studies [54], whereas others have shown that such inconsistencies can be explained
by a compensating gene that is upregulated in the mutants, but not in the morphants [55]. Recent
reports point out off-target single nucleotide variations (SNVs) in CRISPR-repaired mice, fished out via
whole genome sequencing (WGS) [56]. Therefore, if used with the appropriate controls, morpholinos
remain a useful tool [57].
Morpholinos have been employed vigorously to analyze autophagy in zebrafish and have
provided valuable insight into the role of autophagy in development and disease. Knockdown
of Atg5, Atg7 and Beclin1 [58,59], Atg4da [60], Ambra1a and Ambra1b [61,62] all show an important
role of autophagy during embryogenesis. One of the common phenotypes seen consistently
among these studies is a cardiac defect, indicating a very specific role of autophagy in cardiac
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morphogenesis/function, in alignment with previous studies on rodents [63]. Moreover, knockdown of
optineurin, an ubiquitin-binding autophagy-receptor protein, was shown to cause motor axonopathy
due to defective autophagic clearance of accumulated SOD1-G93A aggregates [64], defective
vesicle trafficking in the axons [65], and increased susceptibility to Salmonella enterica infection [66].
Morpholino-mediated depletion of Spns1, a lysosomal transporter, was found to upregulate embryonic
cellular senescence [46] and this was counteracted by the depletion of the lysosomal v-ATPase, which
together suppresses developmental senescence and increases life-span [45]. Transient depletion of
p62/sqstm1, another ubiquitin-binding autophagy receptor protein, in zebrafish embryos was shown
to increase susceptibility to Shigella flexneri and Mycobacterium marinum in the host, indicating the
role of autophagy against bacterial infection [67,68]. In another study involving the knockdown
of p62/sqstm1 in zebrafish, it was seen that the ablation caused a specific locomoter phenotype
characterized by a specific axonopathy of descending motor neuron projections [69]. Sorting nexin
14 knockdown in zebrafish larvae led to neuronal cell death (neurodegeneration) associated with
defective autophagic degradation, ultimately resulting in cerebellar ataxias [70].
Several reports have indicated an indirect escalation or enervation of autophagy in zebrafish
models of gene ablation by morpholinos. Zebrafish embryos depleted of the phosphatidylinositol
3-phosphatase MTMR14 (better known as Jumpy) showed an increase in autophagy at 1 day post
fertilization (dpf) [71], consistent with previous results in mammalian cells, showing that MTMR14
dephosphorylates PI(3)P in the early autophagic membranes, thereby inhibiting autophagy [72]. We
recently found that the PX domain protein Hs1bp3 also regulates the formation of autophagosomes
by a novel negative-feedback mechanism on membrane lipids. Morpholino-mediated depletion of
Hs1bp3 in zebrafish embryos caused an increase in GFP-Lc3 puncta, which was rescued by co-injection
of mRNA encoding the human HS1BP3 protein, thereby validating the conserved role of Hs1bp3 as
negative regulator of autophagy in vivo [73] (Figure 3).
In another study, depletion of collagen VI (COLVI), a protein crucial for structural integrity, cellular
adhesion, migration and survival, resulted in reduced lipidation of Lc3 and reduced expression of
Beclin1, suggesting an overall inhibition of autophagy in these morphants, ultimately leading to muscle
dysfunction [74]. The role of autophagy in survival of hematopoietic cells was observed in a disrupted
ribosome biogenesis model of zebrafish where rps19 was ablated using translation morpholino [75,76].
A detailed list of all morpholinos used to analyze autophagy in zebrafish has been included in another
review [77].
3.4. Mutations
In a major effort to generate mutant zebrafish lines, Christiane Nüsslein-Volhard and Wolfgang
Driever orchestrated two of the largest mutagenesis screens ever performed in zebrafish [24,78]. These
studies brought forth about 1500 mutations in more than 400 genes, but neither these original screens
nor any later screens have revealed a mutant allele of a core autophagy gene. One possible reason for
this could be that such mutations would be early embryonic lethal or it might be explained by the late
onset of autophagy-related phenotypes in zebrafish.
A high quality sequence assembly of the zebrafish genome was initiated by the Sanger Institute
(UK) in 2001 and completed in 2013 [25]. The Sanger Institute also initiated a systematic effort called the
Zebrafish Mutation Project (ZMP) [26], which has created mutant alleles in over 16,000 protein-coding
genes, including a number of core autophagy genes (Table 1). Using such autophagy mutant lines
would provide valuable insight into the role of autophagy in physiological processes.
4. RNA-Based Analysis
Autophagy is known to be tightly regulated by posttranslational modifications of autophagy
proteins (e.g., phosphorylation of ULK1 by mTORC1 and AMPK oppositely regulate the activity of
the ULK1 complex) and by regulation of protein levels. But in order to obtain a real estimation of
autophagy it is necessary to also monitor their mRNA levels [79]. It is however important to note
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that increased mRNA levels of autophagic genes should not be interpreted as increased autophagy,
as it can be a compensatory mechanism. A detailed list of primers used to assess the expression of
autophagy-related genes by quantitative real-time PCR (qRT-PCR) in zebrafish has been reviewed
recently [77]. Zebrafish embryos and larvae are also very suited for whole mount in situ hybridization
(WISH), which provides information about the spatial expression of a particular gene in the whole
organism. This does not aid much in answering questions on autophagy activity, but still could help
analyze the spatial arrangement of autophagy genes under certain conditions. WISH expression
patterns are systematically catalogued in the zebrafish information network (ZFIN) database (zfin.org).
mRNA sequencing is a sensitive and accurate method for analyzing the transcriptomes of
disease states and/or of biological processes. Prior to the activation of the zebrafish embryo genome,
maternally-derived mRNA regulate early development in zebrafish [80,81]. This occurs at the 10th cell
division (~3.5 h post-fertilization) when the zebrafish zygotic genome gets activated, also known as
the mid-blastula transition (MBT) [82]. Mathavan and colleagues applied mRNA deep sequencing
(mRNA-seq) to gain a comprehensive understanding of all transcriptional processes occurring from the
unfertilized egg to early gastrulation [83]. We procured the raw data and fished for “core autophagy
genes” in the data (available in the Gene Expression Omnibus (GEO) database, accession number
GSE22830). Almost all of the core autophagy genes are expressed maternally at quite low levels, except
for map1-lc3c which is expressed at high level from the oocyte to MBT. Interestingly, while the expression
of map1-lc3c tapers off post MBT, there is a correspondingly strong increase in map1-lc3b expression
levels at MBT, suggesting that map1-lc3c plays an important role during the early embryonic cell
divisions, with map1-lc3b being more important later. Wipi2 is consistently highly expressed across the
early cell divisions to gastrulation (Figure 2). Several other mRNA-seq datasets are publicly available
in the GEO database, also covering other later development stages. For example, in a developmental
time series from 1 to 6 days post fertilization it was shown that the autophagy modulator gene dram1
is upregulated during Mycobacterium marinum infection [84].
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5. Protein-based analysis
5.1. Fluorescence Microscopy
The most widely used marker to study autophagy is Atg8/Lc3, as this protein becomes conjugated
to PE in the autophagic membrane upon induction of autophagy and remains bound throughout the
pathway [85]. The lipidated form of Lc3 (called Lc3-II) can be visualized as cytoplasmic puncta by
immunofluorescence microscopy or by a shift in molecular weight when analyzed by sodium dodecyl
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sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (described below). To analyze Lc3 lipidation
in vivo, it is common to measure the increase in Lc3 puncta, using models where the N-terminus of
Lc3 is tagged to a fluorescent reporter protein such as GFP. In zebrafish, GFP-Lc3 can be visualized
in vivo during development due to the transparency of zebrafish embryos (Figure 3). Transgenic
GFP-Lc3 and GFP-Gabarap fish have been generated [86] and are described in more detail below.
Zebrafish larvae beyond 2 dpf develop pigments, which would be a hindrance for normal fluorescent
microscopy. However, larvae can still be visualized for cellular activities in transgenic reporter lines by
supplementing the media with 1-phenyl-2-thiourea (PTU), which inhibits melanogenesis or by using
zebrafish strains that have mutations affecting pigment production [87]. Fusion of autophagosomes
with lysosomes can be readily detected in vivo by the addition of LysoTracker Red to fish media prior
to visualization [86].
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Figure 3. Confocal imaging of Tg(CMV:GFP-Lc3). Representative confocal images of GFP-Lc3 puncta
(autophagosomes) in the trunk area of GFP-Lc3 transgenic zebrafish embryos injected with control
morpholino or Hslbp3 translational-blocking morpholino and imaged at 2 days post fertilization (dpf)
with or without pre-treatment with chloroquine (10 mM) for 6 h. Scale bars, 10 µM for the confocal
images. Panel A, B shows the whole zebrafish larvae at 2 days post fertilization highlighting the trunk
area chosen for confocal imaging; Panel A’, A”, B’, B” shows respective confocal images.
Fluorescence methods (reporter lines or immunofluorescence (IF)) are more sensitive and
quantitative as compared to molecular techniques like western blotting. Increased autophagic activity
is usually marked by a significant change in the number of fluorescent puncta. However, it is very
important to note here that an increase in GFP-Lc3 puncta can be caused by an increased flux or
by impairment of autolysosome formation [79]. Therefore, proper flux experiments must be done
(e.g., stimuli in the absence or presence of lysosomal inhibitors) to be able to conclude. While
quantifying live in vivo images from a reporter line like the GFP-Lc3 line, it has to be done on a
‘per-cell area’ basis rather than simply using the total number (or percentage) of cells displaying
puncta. This point is important as in zebrafish larvae which have a constant supply of nutrients
from the yolk-sac, there could be some cells displaying a basal level of GFP-Lc3 puncta under “fed”
conditions. In situations where endogenous Lc3 could be stained with a specific antibody, it is
important to counterstain the nuclei with DAPI or Hoechst and then quantify puncta on a ‘per-cell’
basis. Another important caveat to be noted when using GFP-Lc3 is its tendency to bind to aggregates,
especially when working with protein-aggregation models or when overexpressed [88]. Interpretation
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of autophagy in these models should be done by negating off the background fluorescence by having
an untagged internal GFP control [79] or by the use of a C-terminal glycine mutant GFP-LC3 that is
defective in ubiquitin-like conjugation with phosphatidylethanolamine, (GFP-LC3G120A as a negative
control) [89] or by another fluorescent protein tandemly fused to GFP, e.g., red fluorescent protein
(RFP) (GFP-RFP-Lc3). Using lysosomal dyes (e.g., LysoTracker Red) in tandem with GFP-Lc3 is another
useful approach [46,86,90]. Here the colocalization of GFP-Lc3 and LysoTracker can be used as an
indicator of autophagy.
The use of transgenic zebrafish models to study autophagy was kick-started by Klionsky
and co-workers who developed the Tg(CMV:GFP-Lc3) and Tg(CMV:GFP-Gabarap) transgenic
lines [86]. The Tg(CMV:GFP-Lc3) line has been used in various studies giving important insights
into the functional significance of autophagy and autophagy modulators in vivo [46,58,67,68,73,91–94].
Tg(fabp10:EGFP-Lc3) and Tg(TαCP:GFP-Lc3) were used recently for looking into autophagy in the
liver [95] and in photoreceptors [90], respectively.
The introduction of the tandem fluorescent tagged Lc3 in mammalian cell lines [96] opened up
for the possibility of making similar tandem tagged (e.g., RFP/mCherry-GFP) reporter lines in model
organisms. As briefly mentioned above, the underlying principle of using a tandem tag to study
autophagy is based on the pH sensitivity of GFP, with the GFP signal being quenched when the tagged
protein reaches the acidic environment of the lysosome, while the red signal (RFP/mCherry) is stable.
Thus, the ratio between yellow (autophagosomes) and red (autolysosomes) signal can readily be used
to quantify autophagic flux. A recent study used a transgenic zebrafish line expressing the tandem tag
for Lc3 under the control of a photoreceptor promoter, Tg(TαCP:mCherry-GFP-map1lc3b) [97]. The
tandem-tag principle can be exploited to generate other zebrafish reporter lines (by tandem-tagging
selective autophagy cargo or autophagic receptors) that would contribute to our understanding of
autophagy and the mechanisms underlying its role in zebrafish development and physiology.
As mentioned earlier, one should be cautious when interpreting Lc3 data. An increase in Lc3
levels should be validated by estimating the total autophagic flux, by e.g., treating samples with and
without lysosomal inhibitors, such as Bafilomycin A1 or chloroquine (Figure 3). There are however
reports that lysosomal inhibitors could inhibit mTORC1 and induce “unwanted” autophagy [98–100].
Taking these loopholes into consideration, the Mizushima group recently constructed a novel probe,
GFP-Lc3-RFP-Lc3∆G, which they tested in zebrafish as well [101]. The transgenic zebrafish line that
ubiquitously expresses Tg(GFP-Lc3-RFP-Lc3∆G) aided robust assessment of autophagic flux by the
measurement of the GFP/RFP ratio. The underlying principle here is that the reporter probe will be
cleaved by endogenous Atg4 proteases into equimolar amounts of GFP-Lc3 and RFP-Lc3∆G, a mutant
unable to become conjugated to the autophagy membrane. Thus, while GFP-Lc3 becomes lipidated
and degraded by autophagy, the RFP-Lc3∆G remains in the cytosol, serving as an internal control.
Autophagic flux can then be estimated by calculating the GFP/RFP signal ratio.
Fluorescent reporter lines of other autophagy core components or probes to detect autophagic
membranes would also be desirable. The zebrafish transgenic reporter lines Tg(TαCP:YFP-2XFYVE)
and Tg(TαCP:tRFP-t-2XFYVE) are examples of the latter. The FYVE domain is a conserved
protein motif characterized by its ability to bind with high specificity to phosphatidylinositol
3-phosphate (PI(3)P), a phosphoinositide highly enriched in early endosomes, but also detected
in early autophagic structures and found to be important for autophagy [102]. These zebrafish
transgenic reporter lines (Tg(TαCP:YFP-2XFYVE) and Tg(TαCP:tRFP-t-2XFYVE)) were recently used to
characterize endolysosomal trafficking events upon ablation of the polyphosphoinositide phosphatase,
Synaptojanin1 (synj1) in cone photoreceptors [97]. A summary of the zebrafish autophagy reporter
lines used in zebrafish can be found in Table 2.
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Tg(TαCP:mCherry-GFP-Map1lc3b) Cone photoreceptors [97]
Tg(TαCP:GFP-Map1lc3b) Cone photoreceptors [97]
Tg(TαCP:YFP-2XFYVE) Cone photoreceptors [97]
Tg(CMV:EGFP-Map1lc3b; CMV:mCherry-Map1lc3b) Ubiquitous [46]
Tg(CMV:EGFP-Gabarapa; CMV:mCherry-Map1lc3b) Ubiquitous [46]
Tg(fabp10: EGFP-Map1lc3b) Liver [95]
Tg(TαCP:GFP-Map1lc3b) Cone photoreceptors [90]
pEGFP–Map1lc3b Transient (embryonic cells) [103]
mCherry-Lc3 mRNA Transient [104,105]
pDest(CMV:RFP.GFP.Lc3) mRNA Transient [105]
GFP-Lc3-RFP-Lc3∆G mRNA Transient [101]
mCherry-Map1lc3b Transient [106]
hsp70l:RFP-Map1lc3b Transient [61]
In cases where there are no stable reporter lines available and one wants to investigate autophagy
during embryonic development (up to 5 dpf or depending upon the half-life of the transcribed
mRNA), it is possible to inject in vitro transcribed mRNA for a reporter tagged to Lc3 or any
other autophagy marker protein, such as mCherry-Lc3 mRNA in vitro transcribed from the vector
pDest(CMV:RFP-GFP-Lc3) [104–106].
5.2. Western Blotting
The most widely used method for analyzing autophagy is by measuring the levels of lipidated or
membrane bound form of Atg8/Lc3B (Atg8-PE/Lc3B-II), as it runs at a different molecular weight than
the cytosolic form of Lc3 (Lc3-I) by SDS-PAGE [79,107]. This method has been used to measure levels
of autophagy in some zebrafish autophagy studies [46,58,86,95,104,106,108,109]. Again, it cannot be
concluded that a mere increase in Lc3-II levels corresponds to increased autophagy, as this can also be
due to autolysosomal formation defects, and it is therefore important to do proper autophagic flux
experiments (as described above) to conclude about increased/reduced autophagy.
It is very critical to differentiate between the lipidated Lc3-II and the unlipidated Lc3-I when
immunoblotting for Lc3. As these two bands lie pretty close to each other (approximately 14 and 16
kDa), one can be masked by the other and this problem is intensified if the zebrafish embryo is not
deyolked prior to preparing the lysate. The yolk sac is enriched with the protein Vitellogenin and this
can cause overloading effects while blotting, if not removed by a deyolking buffer such as Ringer’s
solution [110]. It is also critical to use gels that give a good separation in the 15 kDa area.
Reproduction of Lc3 blots can be a major hindrance, primarily attributed to changes in
experimental setups. The lysis buffer used, the incubation times for blocking, and the primary
and secondary antibodies as well as washing periods should be optimized. The type of membrane
used for blotting also makes a difference, as Lc3-II binds more effectively to the polyvinylidene fluoride
(PVDF) membrane whereas nitrocellulose has a higher affinity for Lc3-I. It is also beneficial to dry the
membrane for a short time after transfer to potentially stabilize the binding of Lc3 to the membranes.
The following should also be taken into consideration while blotting for Lc3: sensitivity issues of
Lc3-I to freeze-thawing (lysates should be run right after boiling), and comparison of Lc3-II levels to
a housekeeping protein (e.g., actin or tubulin) rather than comparing them to Lc3-I, as Lc3-I levels
can vary (e.g., upon cellular stress and from tissue to tissue) and not necessarily represent autophagy
levels. Finally, it is necessary to also monitor the lc3B mRNA levels and to compare the correlation
between protein Lc3B and mRNA lc3B [79].
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Even though Lc3 remains the primary target to reveal levels of autophagy, other core autophagy
proteins have also been studied. Knockdown of Atg5, Atg7 and Beclin1 in zebrafish were validated
via Western blotting in a study aimed at investigating a possible role of autophagy during zebrafish
embryogenesis [58]. Beclin1 levels were also examined in ambra-1 knockdown embryos [62]. A detailed
list of autophagy related antibodies successfully used for Western blotting and immunofluorescence in
zebrafish is shown in Table 3.
Table 3. List of antibodies ever used to detect autophagy-related proteins in zebrafish. (Catalogue
numbers listed in italics have been used for immunostaining too).
Antibody Company Catalogue No. Reference
LC3
Novus biologicals NB100-2220 [93,108,111–116]




















MBL Japan Not indicated [119,120]
Cliniscience PM045 [67]
mTOR Cell Signalling 2983 [116]
Phospho-mTOR, Ser2448 Cell Signaling 2971 [121]
Akt Cell Signaling Not indicated [74]
Phospho-Akt, Ser473 Cell Signaling 9271 [74,121]
Phospho-S6K, Thr389 Cell Signaling 9205 [121]
Phospho-S6K Cell Signaling Not indicated [104]
S6k Cell Signaling 2708 [121]
Beclin1
R&D systems Not indicated [120]
Abcam Not indicated [104]
Santa Cruz H-300 11427 [58,62]
Lamp-2A Abcam ab18528 [121]
Atg5




Abgent AP1812a, AP1812b [59]
Actin (loading control) Sigma Not indicated [108]
α-Tubulin (loading control) Sigma T5168 [73]
GAPDH (loading control) Millipore Not indicated [108]
5.3. Transmission Electron Microscopy (TEM)
Autophagy was first discovered in the 1950s using transmission electron microscopy (TEM) [122].
TEM is a classical and widely used method to observe autophagic structures. If properly sampled, TEM
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provides superlative ultrastructural images with much higher resolution than any light microscope or
super-resolution microscope. It gives details of cellular coats, cellular components and bodies in their
natural environment [79,123].
TEM has been used to a limited extent in zebrafish autophagy research, owing to the
difficulty in sampling and instrument availability. TEM has been used to demonstrate the presence
of autophagosomes during zebrafish embryogenesis [58], during caudal fin [91] and muscle
regeneration [94] and a variety of other contexts. For example, TEM revealed an increased number of
autophagosomes and autolysosomes in the intestinal epithelial cells of zebrafish harboring a mutation
in a ribosomal RNA processing gene, pwp2h [106]. Here increased autophagy enhanced survival of this
zebrafish ribosomopathy model In contrast, aberrant autophagy was observed in a zebrafish motor
dysfunction model [71], in Atrogin1-deficient zebrafish [117] and in a variety of zebrafish bacterial
infection models [67,68,92]. The Salmonella plasmid virulence gene, spvB, was shown to enhance
bacterial virulence by inhibiting autophagy [120].
6. Chemical/Pharmacological Modulations
Zebrafish embryos are easily treatable by waterborne exposure. Drugs that can modulate
autophagic activity by either inducing it, decreasing it or blocking autophagosome-lysosome fusion
have been well-used in zebrafish [124]. A detailed list of reagents used to interfere with autophagic
activity in zebrafish (until 2014) has been reviewed previously [124]. We here present a list of
autophagic modulators used in papers published after 2014 (Table 4, Figure 4).
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Table 4. List of reagents used to modulate autophagic activity in zebrafish (post–2014).
Reagent Conc. Observed Effect Reference
Reagents increasing autophagy
Rapamycin
400 nM Inhibited mTOR, activated autophagy; ameliorated kidney cysts and preserved kidney function [112]
1 µM Increased autophagy dependent release of Tumor necrosis factor α and Interleukin-8 (TNFα and IL-8)in mycobacterium-infected zebrafish larvae [105]
10 µM Enhanced clearance of protein aggregates in FLNCW2710X mutants [113]
30 µM Enhanced the clearance of A152T-tau, reduced hyperphosphorylated tau [108]
Torin1 0.4 µM ATP-competitive mTOR inhibitor; increased Lc3-I and Lc3-II levels; increased resistance of zebrafishembryos to Salmonella Typhimurium infection [119]
Rilmenidine 50 µM Imidazoline-1 receptor agonist, reduced cyclic adenosine monophosphate (cAMP) levels; enhancedthe clearance of A152T-tau [108]
Clonidine 30 µM Imidazoline-1 receptor agonist, reduced cAMP levels; enhanced the clearance of A152T-tau [108]
Carbamazepine
20 µM mTOR-independent autophagy activator; attenuated kidney cysts [112]
50 µM Increased autophagy-dependent cytokine release [105]
0.5 mM Enhanced clearance of protein aggregates in FLNCW271◦X mutants [113]
Minoxidil 400 nM Inhibited L-type Ca
2+ channel currents, thereby activating autophagy via a cyclical mTOR
independent pathway; attenuated kidney cysts
[112]
Auten-67 50 µM Upregulated autophagy by inhibiting phosphatase activity of MTMR14, which is a negative regulatorof autophagic membrane formation. [125]
Spermidine 5 mM Inhibited acetyl-transferases; enhanced clearance of protein aggregates in FLNCW2710X mutants [113]
Trifluoperazine
(TFP) 1 mM
Activated Transcription Factor EB (TFEB) which is a master regulator of autophagy pathway,
activated autophagy [111]
Reagents blocking autophagosome—lysosome fusion
Bafilomycin A1
(BafA1)
20 nM Autophagosome-lysosome fusion inhibitor; slight increase in Lc3-II [117]
25 nM Significant increase in Lc3-II [104]
167 nM Showed defects in autophagy flux [112]
200 nM Zebrafish larvae recapitulated atp6v0ca morphant, reduced yolk opacity and senescence phenotypes [45]
Chloroquine
10 µM Autophagosome-lysosome fusion inhibitor; blocked autophagy and increased GFP-Lc3 punctae [73]
2 mM Reduced muscle regeneration on blocking autophagy [94]
100 c Decreased Lc3 accumulation, defective autophagy [113]
5 µM Increased Lc3 accumulation in Kri1lcas002 mutant [104]
2.5 µM Significant accumulation of autophagosomes in zebrafish larvae infected with mycobacterium [105]
50 µM Accumulation of Lc3-II and p62; no effect on zebrafish infection with Salmonella Typhimurium [119]
Omeprazole 100 µM Late-stage autophagy inhibitor; rescued senescence phenotype [45]
Lansoprazole 100 µM Late-stage autophagy inhibitor; rescued senescence phenotype [45]
Pantoprazole 100 µM Late-stage autophagy inhibitor; rescued senescence phenotype [45]
Pepstatin A 5 µg/mL Prevented autolysosomal maturation and turnover [45]
E-64d 5 µg/mL Prevented autolysosomal maturation and turnover [45]
Ammonium
chloride
100 mM Prevented autolysosome maturation; blocked autophagy and increased GFP-Lc3 punctae [113]
100 mM Significant increase in Lc3-II [117]
Early autophagy inhibitor
3-MA 10 mM Inhibited PIK3C3 activity; significant reduction of autophagy visualized by Lc3-II puncta [104]
7. Selective Autophagy
While induction of autophagy upon nutrient deprivation or other forms of stress is believed to
be an unselective process when it comes to the types of cargo being sequestered and degraded to
supply cells with essential building-blocks to survive the period of stress until cellular homeostasis
is restored. Autophagy can however also be a highly selective process, with different cargo-specific
sub-types, including lipophagy (autophagy of lipid droplets), ferrintinophagy (autophagy of iron
bound ferritin), lysophagy (autophagy of lysosomes), reticulophagy (autophagy of ER), ribophagy
(autophagy of ribosomes), xenophagy (autophagy of pathogens), aggrephagy (autophagy of protein
aggregates) and mitophagy (autophagy of damaged mitochondria). Specific cargo binding proteins
that also interact with Lc3/GABARAP proteins (so-called autophagy receptors) have been identified
and found to facilitate selective autophagy by connecting cargo to the autophagy membrane. Selective
autophagy plays an important house-keeping function under basal nutrient-rich conditions to mediate
the removal of superfluous or damaged organelles and protein aggregates that otherwise could be toxic.
Zebrafish has been used to study degradation of mitochondria and protein aggregates in different
neurodegenerative disorder models and to investigate the role of autophagy in protection against
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pathogens, as reviewed below. For most other types of selective autophagy zebrafish have either been
not used at all or very scarcely used.
7.1. Mitophagy
Selective removal of mitochondria is termed as mitophagy. The degradation of mitochondria by
autophagy was already reported in the late 1950s when Clark and Novikoff observed mitochondria
within membrane-bound compartments called “dense-bodies”, which were later shown to contain
lysosomal enzymes [126,127]. The term mitophagy was coined by Lemasters and colleagues when they
observed the engulfment of mitochondria into vesicular structures coated with Lc3 [128]. Mitophagy is
also seen in yeast and this has helped dissect the molecular machinery required for the process [129,130].
Some of the proteins required for yeast mitophagy do not have a mammalian orthologue (e.g., Atg32,
Atg11), but have functional homologues, e.g., the outer mitochondrial membrane protein NIX acts both
like Atg32 and Atg11 [131]. Mitophagy has also been found to be important during key developmental
processes, such as the maturation of reticulocytes, after which the matured red blood cells lack
mitochondria [132,133].
The E3 ubiquitin ligase Parkin is a major player in mitophagy [134]. Mitochondrial recruitment
of Parkin is mediated by the accumulation of PTEN-induced putative kinase protein 1 (PINK1) on
depolarized mitochondria [135–137]. NIX has also been shown to promote Parkin translocation and
thereby promote mitophagy in mouse embryonic fibroblasts [138]. Loss of function mutations in the
gene encoding Parkin (park2) have been linked to Parkinson’s disease (PD) with loss of dopaminergic
neurons in the substantia nigra, a region in the mid brain that is responsible for motor function [139].
Parkinsonian syndrome has also been shown in zebrafish morphants lacking pink1 [140] and park2 [141],
with dopaminergic cell loss. A TILLING (targeting-induced local lesions in genomes) mutant for pink1
also shows significant reduction in the number of tyrosine hydroxylase (TH)+ cells and a reduction
in mitochondrial complex I activity [142]. Thus, mitophagy dysfunction or an inability to degrade
damaged mitochondria leading to accumulation of mitochondrial damage is a likely cause of PD.
Proteins involved in mammalian mitophagy are well conserved in zebrafish [143], which makes
zebrafish a good model to further delineate the functional significance of mitophagy in vivo. There
have not yet been many mitophagy studies in zebrafish, but several tools exist to study mitochondrial
dynamics. One study tried to observe sites for mitophagy in Rohon Beard neurons of zebrafish where
UAS:LC3.GFP was coinjected with UAS:mitoTagRFP-T into the Isl2b:Gal4 transgenic line. Lc3 was found
to colocalize with mitochondria, but proper mitophagy assays were not performed [144]. It would
be highly interesting to see if Lc3 disappeared over time from these contact points. As mentioned
earlier, a tandem-based approach to tagging mitochondrial proteins would help in observing their
degradation kinetics via autophagy. It is a highly exciting time for zebrafish mitophagy studies. One
major problem is however the lack of antibodies for zebrafish mitochondrial proteins, but with larger
research interest churning up for mitochondrial studies, this scenario is likely to diminish fast.
7.2. Aggrephagy
Several neurodegenerative disorders and prion diseases are characterized by neuronal protein
aggregates and inclusion body formation. Aggregates are formed due the accumulation of misfolded
proteins [145]. Misfolded proteins can either be degraded by the ubiquitin–proteasome system (UPS),
through chaperone-mediated autophagy (CMA) or by macroautophagy. Almost all soluble proteins
(except for the long lived proteins) are turned over by the UPS, but as large protein-aggregates are
difficult to degrade by the UPS, they are degraded by autophagy [146].
The zebrafish is a well-known model for the study of neurodegenerative disorders.
Pharmacological modulation of autophagy in such zebrafish models of neurodegeneration has
shown promising results. The first study to mention autophagy in zebrafish used a zebrafish
Huntington’s disease (HD) model expressing EGFP-HDQ71 aggregates, where autophagy was found
to be upregulated by reagents such as calpastatin, calpeptin, 2′5′DDA and clonidine (Table 2), resulting
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in a decrease in EGFP-HDQ71 aggregates [147]. HD is caused by glutamine expansions (polyQ) in
the gene encoding the Huntingtin protein that make it prone to misfold and aggregate. In another
study using the zebrafish HD model expressing EGFP-HDQ71 it was demonstrated that autophagy
inducers like rapamycin and clonidine cleared the aggregate in the retina [148]. A zebrafish model of
Alzheimer’s disease (AD) is characterized by neuronal tau aggregates and was found to have reduced
aggregate clearance and decreased Lc3-II levels upon overexpression of phosphatidylinositol binding
clathrin assembly protein (Picalm) [114]. PICALMs are known to interact with and thereby regulate
the endocytosis of Soluble NSF Attachment Protein Receptor proteins (SNAREs), such as VAMP2,
VAMP3 and VAMP8 [149]. In a recent study, it was seen that clonidine, rilmenidine and rapamycin
had positive effects on the clearance of aggregated A152T-tau. It was also observed that transient
overexpression of Atg5 upregulated autophagy in zebrafish larvae by 2 dpf, evident by an increase in
lipidated Lc3-II and a reduction in hyperphosphorylated tau—one that causes aggregation of tau [108].
BAG3 is a key component of the chaperone-assisted selective autophagy (CASA) pathway [150]. It was
recently found that in a transgenic zebrafish model of myofibrillar myopathy (induced by expression
of a mutant of filamin C (FLNCW2710X-eGFP)) the BAG3-mediated CASA pathway is impaired and
insufficient in clearing the FLNCW2710X aggregates, and that autophagy promoting compounds like
rapamycin or carbamazepine facilitated aggregate reduction [113].
The zebrafish as a model is proving to be essential for understanding disease mechanisms of
several neurodegenerative disorders characterized by insoluble protein aggregates. There are a
plethora of studies showing reduction of protein aggregates by the induction of autophagy. So far,
molecular studies on the sequestration of aggregates into autophagosomes have not elucidated the
role of different autophagy proteins during aggrephagy in zebrafish. This is very likely to change
in the near future with the advent of CRISPR/Cas9 technology and the availability of antibodies for
protein studies. The transparency of the zebrafish and its amenability to different drugs makes them
an excellent model for neurodegenerative research.
7.3. Xenophagy
The role of autophagy as an anti-microbial mechanism was first demonstrated in studies by
Yoshimori and co-workers, who showed that Streptococcus pyogenes multiplied in Atg5-deficient cells
and by Deretic and co-workers, who showed that intracellular survival of Mycobacterium tuberculosis
could be limited by starvation-induced or rapamycin-induced autophagy [151,152]. Since then
autophagy has become recognized as a crucial defense mechanism against bacterial, viral, fungal,
and protozoan pathogens [14]. Once internalized by host cells, microbial invaders often escape from
phagosomes into the cytosol, where they become targets for xenophagy. Cytoplasmic microbes or
damaged membranes of phagosomes are marked by molecular tags such as ubiquitin and galectins,
which are the substrates for recognition by selective autophagy receptors that are also involved
in mitophagy [153]. The autophagy receptors p62 and optineurin have been shown to protect
against bacterial infections in zebrafish models [66,67]. Autophagy-related mechanisms distinct
from xenophagy also play a role in host defense. In particular, Lc3 can be recruited directly to
phagosomes in a process named Lc3-associated phagocytosis (LAP) [154]. Pathogens have evolved
various strategies to evade xenophagy or LAP [155,156]. Zebrafish models for Salmonella typhimurium
and Mycobacterium marinum infection have been used to study some of the virulence mechanisms
that pathogens use to counteract the host autophagy response [119,120,157]. In addition, it has been
shown that pharmacological stimulation of autophagy can improve the zebrafish host defense against
Mycobacterium marinum infection [105,118].
GFP-Lc3 transgenic zebrafish have been used to study bacterial infections with Shigella flexneri
and M. marinum [67,77,102,158]. Both these pathogens have the ability to escape from phagosomes
and replicate inside the cytosol. A proportion of cytosolic Shigella bacteria are trapped inside
cage-like structures formed by septins, which are cytoskeletal components that prevent Shigella from
actin tail formation and cell-to-cell spreading [159]. In vitro studies have shown that septin-caged
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Shigella are targeted to autophagy [159]. In agreement, in vivo imaging of zebrafish embryos
demonstrated recruitment of GFP-Lc3 and the presence of bacteria in autophagosomes was confirmed
by ultrastructural analysis [67]. Septin-caged M. marinum bacteria were also observed in zebrafish
embryos, but the significance of septin caging in relation to autophagic targeting remains to be
investigated [67]. Entrapment of M. marinum bacteria by GFP-Lc3 vesicles could be visualized by
confocal time lapse imaging of infected zebrafish [92]. This study also revealed that GFP-Lc3 vesicles
frequently appeared as puncta in close vicinity of single bacteria or bacterial clusters (Figure 5).
Correlative light and electron microscopy confirmed that these vesicles represent autophagosomes,
which might contribute to the delivery of ubiquitinated antimicrobial peptides to the M. marinum
-containing compartments [92,160].
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Dram1 is an autophagy modulator that is induced during infection of zebrafish by the
MYD88-NFκB-dependent signaling pathway, which occurs downstream of pathogen recognition
by Toll-like receptors [68]. Expression of zebrafish Dram1 can also be induced by the p53-stabilizing
agent roscovitin, in agreement with the identification of human DRAM1 as a p53 target gene [68,161].
Overexpression of Dram1 by mRNA injection was found to result in increased lysosomal acidification
of M. marinum containing compartments and to improve resistance of zebrafish embryos to the
infection [68]. In addition, Dram1 overexpression enhances GFP-Lc3 recruitment to M. marinum
and this function requires the cytosolic DNA sensor Sting and the ubiquitin receptor p62. In
agreement, morpholino knockdown of Dram1 reduced GFP-Lc3 recruitment to M. marinum and
impaired host defense [68]. Dram1 is a member of a conserved family of transmembrane proteins
and localizes predominantly to lysosomes [161]. Its precise mechanism of action is currently
unknown, but a recent study on a human family member, DRAM2, suggests an interaction with
the Beclin1-Vps34-UVRAG complex, which leads to displacement of the inhibitor Rubicon and thereby
enhanced PI3K activity [162]. Since M. marinum infection in zebrafish mimics aspects of human
tuberculosis, further research into the Dram1-mediated selective autophagy pathway could help to
develop novel strategies for host-directed anti-tuberculosis therapy [160].
Recently, the zebrafish has also been used to study the host autophagic response to a viral
infection [109]. Zebrafish can be infected with spring viremia of carp virus (SVCV), a member of the
rhabdovirus family. Infection with this virus induces the production of Tnfα, a potent pro-inflammatory
cytokine that normally serves a host-protective function, but is exploited by certain viruses to their
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benefit. GFP-Lc3 imaging and Western blot analysis showed that depletion of Tnfα increased
autophagy in SVCV-infected larvae. Since depletion of Tnfα also improved resistance to SVCV
infection, the authors concluded that inhibition of autophagy is the mechanism behind the deleterious
effect of Tnfα on viral clearance [109]. A wide variety of other zebrafish infection models provide
excellent tools to further advance our understanding of the role of autophagy in host-pathogen
interactions [163].
8. Future Perspective
The zebrafish is fast becoming one of the best vertebrate models for studying disease states
and conditions. Owing to the various advantages that they pose and the ease at which the present
advancements in genome editing technology can be applied, zebrafish hold unparalleled potential
for all basic and translational research. Existing studies of autophagy in zebrafish have presented
invaluable insight into the role of autophagy in development, disease progression and drug discovery.
There is still however a need for antibodies that recognize specific zebrafish autophagy proteins, and
their modifications (at present a limitation). The contribution of CRISPR/Cas9 to scientific research
has been immense, but the overall technology depends upon efficient sgRNAs and thus having a
database system to maintain and expand the existing sgRNAs is a must. Autophagy research has been
expanding and the vitality of autophagy as a degradation system has been acknowledged worldwide
with Yoshinori Ohsumi receiving the Nobel Prize in Medicine or Physiology in 2016. Autophagy
research using the zebrafish as a model system looks promising for many more breakthroughs and
new therapeutics against many diseases.
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